The Signal Expert insights and opinions on clinical research and drug development. Expert insights and opinions on clinical research and drug development. ISCTM Autumn Conference 2021: Poster Presentations Roundup October 5, 2021 Signant Health Posted in Events The International Society for CNS Clinical Trials and Methods (ISCTM) hosted its 2021 Autumn Conference from Sept 30 – October… Read More eCOA Best Practices: Ensuring Timely Delivery of Translations October 4, 2021 Signant Health Posted in eCOA With more than half of all registered studies occurring in locations outside of the U.S. and the continued upward trajectory… Read More Selecting a Fit-For-Purpose Device September 28, 2021 Bill Byrom Posted in eCOA In today’s protocols, we continue to see an increased appetite to study clinical endpoints derived from wearables and sensors (i.e.,… Read More eConsent Task Force Co-Chaired by Signant and Medidata Honored as Finalists for TOPRA Innovation Award September 16, 2021 Signant Health Posted in eConsent In 2019, a team of industry experts formed a task force to examine challenges and opportunities in the adoption of… Read More 3 Reasons Oncology Studies Should Consider a Pre-Configured eCOA Solution September 2, 2021 Signant Health Posted in eCOA The FDA’s recent guidance placed an increased emphasis on patient-reported outcome measures (PROMs) for oncology trials. This data provides better insight into the patients’ disease-related symptoms, side effects of treatment, and effect… Read More EMA Draft Guidance: Here’s What It Tells Us About BYOD August 31, 2021 Bill Byrom Posted in eCOA The European Medicines Agency (EMA) draft guidance released this past June on “computerized systems and electronic data in clinical trials” to replace their 2010 reflection paper on… Read More Direct-to-Patient Clinical Supply Distribution: Everything You Need to Know August 27, 2021 Signant Health Posted in Clinical Supplies The adoption of decentralized studies has rapidly increased thanks in part to the recent pandemic, which encouraged regulators to permit more flexibility within protocols and forced sponsors to implement… Read More The Inaugural IMAGINE FORUM Recap August 25, 2021 Signant Health Posted in Telemedicine & Virtual Monitoring At Signant Health, we believe progress is best done together. That’s why we launched the Imagine Forum to promote industry-wide collaboration and thoughtful discussion. … Read More AAIC 2021 Recap August 24, 2021 Signant Health Posted in Scientific Advisory Here are a few takeaways from Signant’s presentations that you may have missed: Dr. Miller led a product showcase, Glimmers… Read More Key Technology Elements for Successful Hybrid Trials August 20, 2021 Bill Byrom Posted in eCOA As the industry continues to predict and debate what the “new normal” in clinical development will look like in an… Read More Previous 1 … 4 5 6 7 Next
ISCTM Autumn Conference 2021: Poster Presentations Roundup October 5, 2021 Signant Health Posted in Events The International Society for CNS Clinical Trials and Methods (ISCTM) hosted its 2021 Autumn Conference from Sept 30 – October… Read More eCOA Best Practices: Ensuring Timely Delivery of Translations October 4, 2021 Signant Health Posted in eCOA With more than half of all registered studies occurring in locations outside of the U.S. and the continued upward trajectory… Read More Selecting a Fit-For-Purpose Device September 28, 2021 Bill Byrom Posted in eCOA In today’s protocols, we continue to see an increased appetite to study clinical endpoints derived from wearables and sensors (i.e.,… Read More eConsent Task Force Co-Chaired by Signant and Medidata Honored as Finalists for TOPRA Innovation Award September 16, 2021 Signant Health Posted in eConsent In 2019, a team of industry experts formed a task force to examine challenges and opportunities in the adoption of… Read More 3 Reasons Oncology Studies Should Consider a Pre-Configured eCOA Solution September 2, 2021 Signant Health Posted in eCOA The FDA’s recent guidance placed an increased emphasis on patient-reported outcome measures (PROMs) for oncology trials. This data provides better insight into the patients’ disease-related symptoms, side effects of treatment, and effect… Read More EMA Draft Guidance: Here’s What It Tells Us About BYOD August 31, 2021 Bill Byrom Posted in eCOA The European Medicines Agency (EMA) draft guidance released this past June on “computerized systems and electronic data in clinical trials” to replace their 2010 reflection paper on… Read More Direct-to-Patient Clinical Supply Distribution: Everything You Need to Know August 27, 2021 Signant Health Posted in Clinical Supplies The adoption of decentralized studies has rapidly increased thanks in part to the recent pandemic, which encouraged regulators to permit more flexibility within protocols and forced sponsors to implement… Read More The Inaugural IMAGINE FORUM Recap August 25, 2021 Signant Health Posted in Telemedicine & Virtual Monitoring At Signant Health, we believe progress is best done together. That’s why we launched the Imagine Forum to promote industry-wide collaboration and thoughtful discussion. … Read More AAIC 2021 Recap August 24, 2021 Signant Health Posted in Scientific Advisory Here are a few takeaways from Signant’s presentations that you may have missed: Dr. Miller led a product showcase, Glimmers… Read More Key Technology Elements for Successful Hybrid Trials August 20, 2021 Bill Byrom Posted in eCOA As the industry continues to predict and debate what the “new normal” in clinical development will look like in an… Read More Previous 1 … 4 5 6 7 Next